• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞米唑仑通过靶向METTL3介导的P53的m6A修饰减轻缺氧/复氧处理的人胚胎肝细胞系的损伤。

Remimazolam relieved the injury of hypoxia/reperfusion treated human embryo liver cell line through the targeting METTL3 mediated m6A modification of P53.

作者信息

Ding Weixing, Peng Huijuan, Tian Jianyou, Wang Siyan

机构信息

Pain Department, Qujing Second People's Hospital, No. 289 Qilin Xi Road, Qilin District, Qujing, Yunnan, 655009, China.

Anesthesiology Department, Qujing Second People's Hospital, No. 289 Qilin Xi Road, Qilin District, Qujing, Yunnan, 655009, China.

出版信息

Heliyon. 2023 Sep 21;9(9):e20285. doi: 10.1016/j.heliyon.2023.e20285. eCollection 2023 Sep.

DOI:10.1016/j.heliyon.2023.e20285
PMID:37809663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10560062/
Abstract

BACKGROUND

This study was performed to explore the role of Re in liver IRI progression. Hypoxia and reperfusion (H/R) treated human embryo liver cell line (L-02) was used to establish a liver IRI model.

MATERIALS AND METHODS

Cell behaviors were detected using CCK-8, flow cytometry and TUNEL staining assays. The m6A content was detected using m6A dot blot assay. RT-qPCR and western blot assays were used to assessed the relative mRNA and protein levels. MeRIP assay was conducted to determine the m6A levels of P53. The relationship between METTL3 and P53 was demonstrated using RIP and dual-luciferase reporter assays.

RESULTS

The results showed that Re treatment significantly decreased the cell apoptosis and promoted the cell viability in the H/R treated L-02 cells. Besides, H/R treatment increased the METTL3 and m6A levels in the L-02 cells, and Re treatment decreased them. Additionally, METTL3 overexpression reversed the role of Re in the H/R treated L-02 cells. Mechanistically, METTL3 overexpression enhanced the m6A levels and mRNA stability and expressions of P53. The combination of METTL3 and P53 was further confirmed.

CONCLUSION

In conclusion, this study demonstrated that Re treatment relieved the H/R induced injury in the L-02 cells through decreasing the METTL3 levels. METTL3 enhanced the mRNA stability and expressions of P53 through m6A modification. Re-METTL3-P53 axis might a new direction for the treatment of liver IRI in the future.

摘要

背景

本研究旨在探讨白藜芦醇(Re)在肝脏缺血再灌注损伤(IRI)进展中的作用。采用缺氧复氧(H/R)处理的人胚胎肝细胞系(L-02)建立肝脏IRI模型。

材料与方法

使用CCK-8、流式细胞术和TUNEL染色法检测细胞行为。采用m6A斑点印迹法检测m6A含量。运用RT-qPCR和蛋白质免疫印迹法评估相关mRNA和蛋白质水平。进行甲基化RNA免疫沉淀(MeRIP)分析以确定P53的m6A水平。通过RNA免疫沉淀(RIP)和双荧光素酶报告基因检测法证明甲基转移酶样蛋白3(METTL3)与P53之间的关系。

结果

结果显示,白藜芦醇处理显著降低了H/R处理的L-02细胞的凋亡率并提高了细胞活力。此外,H/R处理增加了L-02细胞中METTL3和m6A的水平,而白藜芦醇处理则降低了它们。此外,METTL3过表达逆转了白藜芦醇在H/R处理的L-02细胞中的作用。机制上,METTL3过表达增强了m6A水平以及P53的mRNA稳定性和表达。进一步证实了METTL3与P53的结合。

结论

总之,本研究表明白藜芦醇处理通过降低METTL3水平减轻了H/R诱导的L-02细胞损伤。METTL3通过m6A修饰增强了P53的mRNA稳定性和表达。Re-METTL3-P53轴可能是未来治疗肝脏IRI的新方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a3/10560062/6b26bf5b068c/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a3/10560062/ed3a1b5d4828/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a3/10560062/17838402636c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a3/10560062/f09fc4790d42/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a3/10560062/e3730964ea76/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a3/10560062/c3109c2622b5/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a3/10560062/6b26bf5b068c/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a3/10560062/ed3a1b5d4828/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a3/10560062/17838402636c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a3/10560062/f09fc4790d42/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a3/10560062/e3730964ea76/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a3/10560062/c3109c2622b5/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a3/10560062/6b26bf5b068c/gr6.jpg

相似文献

1
Remimazolam relieved the injury of hypoxia/reperfusion treated human embryo liver cell line through the targeting METTL3 mediated m6A modification of P53.瑞米唑仑通过靶向METTL3介导的P53的m6A修饰减轻缺氧/复氧处理的人胚胎肝细胞系的损伤。
Heliyon. 2023 Sep 21;9(9):e20285. doi: 10.1016/j.heliyon.2023.e20285. eCollection 2023 Sep.
2
METTL3 relieved the injury of SH-SY5Y cells treated with lipopolysaccharide and exposed to sevoflurane through regulating the m6A levels of Sox2.METTL3 通过调节 Sox2 的 m6A 水平缓解脂多糖处理和七氟醚暴露的 SH-SY5Y 细胞损伤。
Brain Behav. 2023 May;13(5):e2936. doi: 10.1002/brb3.2936. Epub 2023 Mar 28.
3
METTL3 contributes to renal ischemia-reperfusion injury by regulating Foxd1 methylation.METTL3 通过调控 Foxd1 甲基化促进肾缺血再灌注损伤。
Am J Physiol Renal Physiol. 2020 Nov 1;319(5):F839-F847. doi: 10.1152/ajprenal.00222.2020. Epub 2020 Sep 21.
4
Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1.METTL3通过上调m6A NOTCH1修饰和抑制NOTCH1对人主动脉平滑肌细胞进行调控。
Ann Transl Med. 2023 Aug 30;11(10):350. doi: 10.21037/atm-22-1203. Epub 2023 Feb 2.
5
The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.m6A 甲基转移酶 METTL3 介导的 DEK mRNA 的 N6-甲基腺苷化修饰促进胃癌细胞生长和转移。
Int J Mol Sci. 2022 Jun 9;23(12):6451. doi: 10.3390/ijms23126451.
6
Donor graft METTL3 gene transfer ameliorates rat liver transplantation ischemia-reperfusion injury by enhancing HO-1 expression in an mA-dependent manner.供体 METTL3 基因转移通过增强 HO-1 的表达以 mA 依赖的方式改善大鼠肝移植缺血再灌注损伤。
Clin Immunol. 2023 Jun;251:109325. doi: 10.1016/j.clim.2023.109325. Epub 2023 Apr 6.
7
METTL3-mediated m6A Modification of hsa_circ_0131922 Attenuates the Progression of Papillary Thyroid Cancer by Regulating the p53 Pathway.METTL3介导的hsa_circ_0131922的m6A修饰通过调控p53通路减弱甲状腺乳头状癌的进展。
Endocr Metab Immune Disord Drug Targets. 2025;25(6):492-502. doi: 10.2174/0118715303290063240530053252.
8
METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy.METTL3/YTHDF2 m6A 轴通过表观遗传抑制 PINK1 和线粒体自噬来介导糖尿病肾病的进展。
J Diabetes Investig. 2024 Mar;15(3):288-299. doi: 10.1111/jdi.14113. Epub 2023 Nov 28.
9
KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer's disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1.KDM1A 介导的 METTL3 上调通过增强 p-Tau 的自噬清除来改善阿尔茨海默病,其通过 m6A 依赖性调节 STUB1 实现。
Free Radic Biol Med. 2023 Feb 1;195:343-358. doi: 10.1016/j.freeradbiomed.2022.12.099. Epub 2022 Dec 30.
10
Aging-Associated Differences in Epitranscriptomic m6A Regulation in Response to Acute Cardiac Ischemia/Reperfusion Injury in Female Mice.雌性小鼠急性心肌缺血/再灌注损伤后,表观转录组m6A调控与衰老相关的差异
Front Pharmacol. 2021 Aug 3;12:654316. doi: 10.3389/fphar.2021.654316. eCollection 2021.

引用本文的文献

1
Remimazolam alleviates hepatic ischemia-reperfusion injury by activating FOXO1/3 signaling : Remimazolam alleviates hepatic ischemia reperfusion injury.瑞马唑仑通过激活FOXO1/3信号通路减轻肝脏缺血再灌注损伤:瑞马唑仑减轻肝脏缺血再灌注损伤。
BMC Gastroenterol. 2025 Apr 22;25(1):283. doi: 10.1186/s12876-025-03820-3.

本文引用的文献

1
The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression.甲基转移酶 METTL3 负调控非酒精性脂肪性肝炎(NASH)进展。
Nat Commun. 2021 Dec 10;12(1):7213. doi: 10.1038/s41467-021-27539-3.
2
Remimazolam Protects Against LPS-Induced Endotoxicity Improving Survival of Endotoxemia Mice.瑞马唑仑可预防脂多糖诱导的内毒素血症,提高内毒素血症小鼠的存活率。
Front Pharmacol. 2021 Nov 19;12:739603. doi: 10.3389/fphar.2021.739603. eCollection 2021.
3
The METTL3/MALAT1/PTBP1/USP8/TAK1 axis promotes pyroptosis and M1 polarization of macrophages and contributes to liver fibrosis.
METTL3/MALAT1/PTBP1/USP8/TAK1轴促进巨噬细胞焦亡和M1极化,并导致肝纤维化。
Cell Death Discov. 2021 Nov 27;7(1):368. doi: 10.1038/s41420-021-00756-x.
4
Sedation outcomes for remimazolam, a new benzodiazepine.瑞马唑仑(一种新型苯二氮䓬类药物)镇静效果评价。
J Oral Sci. 2021 Jun 29;63(3):209-211. doi: 10.2334/josnusd.21-0051. Epub 2021 Jun 7.
5
Remimazolam alleviates neuropathic pain via regulating bradykinin receptor B1 and autophagy.瑞马唑仑通过调节缓激肽受体B1和自噬减轻神经性疼痛。
J Pharm Pharmacol. 2021 Dec 7;73(12):1643-1651. doi: 10.1093/jpp/rgab080.
6
The p53/p21/p16 and PI3K/Akt signaling pathways are involved in the ameliorative effects of maltol on D-galactose-induced liver and kidney aging and injury.p53/p21/p16 和 PI3K/Akt 信号通路参与了麦芽酚对 D-半乳糖诱导的肝肾功能衰老和损伤的改善作用。
Phytother Res. 2021 Aug;35(8):4411-4424. doi: 10.1002/ptr.7142. Epub 2021 May 24.
7
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.抑癌基因 p53:生物学、信号通路和治疗靶点。
Biochim Biophys Acta Rev Cancer. 2021 Aug;1876(1):188556. doi: 10.1016/j.bbcan.2021.188556. Epub 2021 Apr 29.
8
METTL3 contributes to renal ischemia-reperfusion injury by regulating Foxd1 methylation.METTL3 通过调控 Foxd1 甲基化促进肾缺血再灌注损伤。
Am J Physiol Renal Physiol. 2020 Nov 1;319(5):F839-F847. doi: 10.1152/ajprenal.00222.2020. Epub 2020 Sep 21.
9
METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.METTL3 和 N6-甲基腺苷通过调节 DNA-RNA 杂交积累促进同源重组介导的 DSB 修复。
Mol Cell. 2020 Aug 6;79(3):425-442.e7. doi: 10.1016/j.molcel.2020.06.017. Epub 2020 Jul 1.
10
RNA m A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy.RNA mA 甲基化通过 FOXO3 介导的自噬调节肝癌对索拉非尼的耐药性。
EMBO J. 2020 Jun 17;39(12):e103181. doi: 10.15252/embj.2019103181. Epub 2020 May 5.